Hemicrania Continua

Unilateral throbbing headaches may present similar signs and symptoms as dental pathology and are a diagnostic challengefor dental practitioners. Cases may be seen with a primary complaint of unilateral pain or referred by medical colleagues for exclusion of dental causes. In the present article the authors add a new case of hemicrania continua (HC), which is one such unilateral headache, and review the previously published cases. HC is relatively easy to treat since it responds completely to treatment with indomethacin. However, as is presented in this case, HC may masquerade as dental pain. Cases secondary to trauma, systemic disease, and nervous system pathology have been described in the literature, and the clinician must exclude these possible causes. A thorough knowledge of this entity is therefore essential.

headache; facial pain; dental pain; chronic; daily headache; indomethacin

1. Olesen J, Bes A, Kunkel R, et al. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(suppl 7).

2. Silberstein SD, Lipton RB, Solomon S, Mathew NT. Classification of daily and near-daily headaches: Proposed revisions to the IHS criteria. Headache 1994;34(1):1–7.

3. Nappi G, Granella F, Sandrini G, Manzoni GC. Chronic daily headache. How should it be included in the IHS classification? Headache 1999;39:197–203.

4. Olesen J, Rasmussen BK. The International Headache Society classification of chronic daily and near-daily headaches: A critique of the criticism. Cephalalgia 1996;16(6):407–411.

5. Manzoni GC, Granella F, Sandrini G, Cavallini A, Zanferrari C, Nappi G. Classification of chronic daily headache by International Headache Society criteria: Limits and new proposals. Cephalalgia 1995;15(1):37–43.

6. Solomon S, Lipton RB, Newman LC. Evaluation of chronic daily headache—Comparison to criteria for chronic tension-type headache. Cephalalgia 1992;12(6):365–368.

7. Deleu D, Hanssens Y. Primary chronic daily headache: Clinical and pharmacological aspects. A clinic-based study in Oman. Headache 1999;39:432–436.

8. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: Field trial of revised IHS criteria. Neurology 1996;47(4):871–875. [See comments 1997;49(2):638–639.]

9. Sjaastad O, Spierings EL. “Hemicrania continua”: Another headache absolutely responsive to indomethacin. Cephalalgia 1984;4(1):65–70.

10. Bordini C, Antonaci F, Stovner LJ, Schrader H, Sjaastad

O. “Hemicrania continua”: A clinical review. Headache 1991;31(1):20–26.

11. Newman LC, Lipton RB, Solomon S. Hemicrania continua: Ten new cases and a review of the literature. Neurology 1994;44(11):2111–2114. [See comments 1995;45(10):1948–1949;45(12):2302–2303.]

12. Centonze V, Attolini E, Campanozzi F, et al. “Hemicrania continua”: A new clinical entity or a further development from cluster headache? A case report. Cephalalgia 1987;7(3):167–168.

13. Iordanidis T, Sjaastad O. Hemicrania continua: A case report. Cephalalgia 1989;9(4):301–303.

14. Pareja JA, Palomo T, Gorriti MA, et al. Hemicrania continua. The first Spanish case: A case report. Cephalalgia 1990;10(3):143–145.

15. Pasquier F, Leys D, Petit H. “Hemicrania continua”: The first bilateral case? Cephalalgia 1987;7(3):169–170.

16. Sjaastad O, Tjorstad K. “Hemicrania continua”: A third Norwegian case. Cephalalgia 1987;7(3):175–177.

17. Spierings EL. The chronic paroxysmal hemicrania concept expanded. Headache 1988;28(9):597–598.

18. Zukerman E, Hannuch SN, Carvalho DS, Fragoso YD, Jenger KA. “Hemicrania continua”: A case report. Cephalalgia 1987;7(3):171–173.

19. Evers S, Bahra A, Goadsby PJ. Coincidence of familial hemiplegic migraine and hemicrania continua? A case report. Cephalalgia 1999;19(5):533–535.

20. Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. Brain 1997;120(Pt 1):193–209.

21. Pareja JA. Hemicrania continua: Ocular discomfort heralding painful attacks. Funct Neurol 1999;14(2):93–95.

22. Solomon S, Newman LC. Chronic daily bilateral headache responsive to indomethacin. Headache 1999;39:754–757.

23. Fragoso YD, Machado PC. Hemicrania continua with onset at an early age. Headache 1998;38(10):792–793.

24. Newman LC, Lipton RB, Russell M, Solomon S. Hemicrania continua: Attacks may alternate sides. Headache 1992;32(5):237–238.

25. Trucco M, Antonaci F, Sandrini G. Hemicrania continua: A case responsive to piroxicam-beta-cyclodextrin. Headache 1992;32(1):39–40.

26. Pareja JA. Hemicrania continua: Remitting stage evolved from the chronic form. Headache 1995;35(3):161–162.

27. Pareja JA, Palomo T, Gorriti MA, Pareja J, Espejo J. “Hemicrania episodica”—A new type of headache or a pre-chronic stage of hemicrania continua? Headache 1990;30(6):344–346.

28. Goadsby PJ. Short-lasting primary headaches: Focus on trigeminal automatic cephalgias and indomethacin-sensitive headaches. Curr Opin Neurol 1999;12(3):273–277.

29. Moskowitz MA. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 1993;43(6 Suppl 3):S16–S20.

30. Moskowitz MA. Trigeminovascular system. Cephalalgia 1992;12(3):127.

31. Moskowitz MA. The neurobiology of vascular head pain. Ann Neurol 1984;16(2):157–168.

32. Moskowitz MA, Cutrer FM. Possible importance of neurogenic inflammation within the meninges to migraine headaches. In: Fields HL, Liebeskind JC (eds). Progress in Pain Research and Management. Vol 1: Pharmacological approaches to the treatment of chronic pain: New concepts and critical issues: The Bristol-Myers Squibb Symposium on Pain Research. Seattle: IASP Press, 1994:43–49.

33. Pareja JA, White LR, Sjaastad O. Pathophysiology of headaches with a prominent vascular component. Pain Res Manage 1996;1(2):93–108.

34. Antonaci F. Chronic paroxysmal hemicrania and hemicrania continua: Orbital phlebography and MRI studies. Headache 1994;34(1):32–34.

35. Antonaci F, Sandrini G, Danilov A, Sand T. Neurophysiological studies in chronic paroxysmal hemicrania and hemicrania continua. Headache 1994;34(8):479–483.

36. Antonaci F, Sand T, Sjaastad O. Hemicrania continua and chronic paroxysmal hemicrania: A comparison of pupillometric findings. Funct Neurol 1992;7(5):385–389.

37. Sjaastad O, Spierings EL, Saunte C, Wysocka Bakowska MM, Sulg I, Fredriksen TA. “Hemicrania continua.” An indomethacinresponsive headache. II. Autonomic function studies. Cephalalgia 1984;4(4):265–73.

38. Antonaci F. The sweating pattern in “hemicrania continua”. A comparison with chronic paroxysmal hemicrania. Funct Neurol 1991;6(4):371–375.

39. Benoliel R, Sharav Y. Paroxysmal hemicrania. Case studies and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85(3):285–292.

40. Sjaastad O, Joubert J, Elsas T, Bovim G, Vincent M. Hemicrania continua and cervicogenic headache. Separate headaches or two faces of the same headache? Funct Neurol 1993;8(2):79–83.

41. Sjaastad O, Stovner LJ, Stolt-Nielsen A, Antonaci F, Fredriksen TA. CPH and hemicrania continua: Requirements of high indomethacin dosages—An ominous sign? Headache 1995;35(6):363–367.

42. Rothbart P. Unilateral headache with features of hemicrania continua and cervicogenic headache—A case report. Headache 1992;32(9):459–460.

43. Antonaci F, Pareja JA, Caminero AB, Sjaastad O. Chronic paroxysmal hemicrania and hemicrania continua: Anaesthetic blockades of pericranial nerves. Funct Neurol 1997;12(1):11–15.

44. Benoliel R, Elishoov H, Sharav Y. Orofacial pain with vascular-type features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84(5):506–512.

45. Antonaci F, Sjaastad O. Chronic paroxysmal hemicrania (CPH): A review of the clinical manifestations. Headache 1989;29(10):648–656.

46. Bittar G, Graff-Radford SB. A retrospective study of patients with cluster headaches. Oral Surg Oral Med Oral Pathol 1992;73(5):519–525.

47. Brooke RI. Periodic migrainous neuralgia: A cause of dental pain. Oral Surg Oral Med Oral Pathol 1978;46(4): 511–516.

48. Antonaci F, Sjaastad O. Hemicrania continua: A possible symptomatic case, due to mesenchymal tumor. Funct Neurol 1992;7(6):471–474.

49. Warner JS. Analgesic rebound as a cause of hemicrania continua. Neurology 1997;48(6):1540–1541.

50. Young WB, Silberstein SD. Hemicrania continua and symptomatic medication overuse. Headache 1993;33(9): 485–487.

51. Mirsattari SM, Power C, Nath A. Primary headaches in HIV-infected patients. Headache 1999;39:3–10.

52. Brilla R. Evers S, Soros P, Husstedt IW. Hemicrania continua in an HIV-infected outpatient. Cephalalgia 1998;18(5):287–288.

53. Lay CL, Newman LC. Posttraumatic hemicrania continua. Headache 1999;39:275–279.

54. Benoliel R, Eliav E, Elishoov H, Sharav Y. Diagnosis and treatment of persistent pain after trauma to the head and neck. J Oral Maxillofac Surg 1994;52(11):1138–1147; discussion 1147–1148.

55. Pareja J, Sjaastad O. Chronic paroxysmal hemicrania and hemicrania continua. Interval between indomethacin administration and response. Headache 1996;36(1):20–23.

56. Antonaci F, Pareja JA, Caminero AB, Sjaastad O. Chronic paroxysmal hemicrania and hemicrania continua. Parenteral indomethacin: The ‘indotest’. Headache 1998;38(2):122–128.

57. Kuritzky A. Indomethacin-resistant hemicrania continua. Cephalalgia 1992;12(1):57–59.

58. Kumar KL, Bordiuk JD. Hemicrania continua: A therapeutic dilemma [letter]. Headache 1991;31(5):345.

59. Sjaastad O, Antonaci F. A piroxicam derivative partly effective in chronic paroxysmal hemicrania and hemicrania continua. Headache 1995;35(9):549–550.

60. Antonaci F, Pareja JA, Caminero AB, Sjaastad O. Chronic paroxysmal hemicrania and hemicrania continua: Lack of efficacy of sumatriptan. Headache 1998;38(3):197–200.

61. Insel PA. Analgesic-antipyretic and anti inflammatory drugs employed in the treatment of gout. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW (eds). Goodman and Gilman’s The Pharmacological Basis of Therapeutics. New York: McGraw-Hill, 1996:633–634.

62. Tfelt-Hansen P, Stewart Johnson E. Nonsteroidal antiinflammatorry drugs in the treatment of the acute migraine attack. In: Olesen J, Tfelt-Hansen P, Welch KMA (eds). The Headaches. New York: Raven Press, 1993:305–311.

63. Speziale MV, Allen RG, Henderson CR, Barrington KJ, Finer NN. Effects of ibuprofen and indomethacin on the regional circulation in newborn piglets. Biol Neonate 1999;76(4):242–252.

64. Wennmalm A, Carlsson A, Edlund S, Eriksson L, Kaijser L, Nowak J. Central and peripheral haemodynamic effects of non-steroidal anti-inflammatory drugs in man. Arch Toxicol Suppl 1984;7:350–359.

65. Vincent MB. Cyclooxygenase inhibitors modify the relaxant effect of vasoactive intestinal polypeptide and substance P in isolated porcine ophthalmic artery. Cephalalgia 1992;12(1):15–19.

66. Bakken IJ, Vincent MB, White LR, Cappelen J, Skaanes KO, Sjaastad O. Low concentrations of lithium and cyclooxygenase inhibitors enhance endothelin-1 (ET-1)-induced contractions in human temporal artery, but not in porcine ophthalmic artery. Headache 1992;32(10):475–479.

67. Dahl A, Russell D, Nyberg-Hansen R, Rootwelt K. Cluster headache: Transcranial Doppler ultrasound and rCBF studies. Cephalalgia 1990;10(2):87–94.

68. Moskowitz MA. Interpreting vessel diameter changes in vascular headaches. Cephalalgia 1992;12(1):5–7.

69. Moskowitz MA, Brody M, Liu-Chen LY. In vitro release of immunoreactive substance P from putative afferent nerve endings in bovine pia arachnoid. Neuroscience 1983;9(4):809–814.

70. Buzzi MG, Carter WB, Shimizu T, Heath H III, Moskowitz MA. Dihydroergotamine and sumatriptan attenuate levels of CGRPin plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion. Neuropharmacology 1991;30(11):1193–1200.

71. Buzzi MG, Moskowitz MA. The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol 1990;99(1):202–206.

72. Buzzi MG, Moskowitz MA, Peroutka SJ, Byun B. Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater. Br J Pharmacol 1991;103(2):1421–1428.

73. Nozaki K, Moskowitz MA, Boccalini P. CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges. Br J Pharmacol 1992;106(2):409–415.